Amgen (AMGN)
(Delayed Data from NSDQ)
$278.39 USD
+1.02 (0.37%)
Updated May 2, 2024 04:00 PM ET
Pre-Market: $313.05 +34.66 (12.45%) 9:12 AM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AMGN 278.39 +1.02(0.37%)
Will AMGN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMGN
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in the Cards for Amgen (AMGN) This Earnings Season?
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Other News for AMGN
Oppenheimer Remains a Buy on Amgen (AMGN)
Amgen (AMGN) Receives a Buy from Piper Sandler
Amgen up due to positive obesity data, says Jefferies
AMGN Earnings: Amgen Surges After Raised Forecast, Weight Loss Drug Update
Amgen price target raised by $23 at UBS, here's why